Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants

Abdullah, Nor Azizan; Jalal, Nazihah Abd; Ismail, Napsiah; Kamaruddin, Mohd Arman; Mutalib, Nurul Syakima Abd; Alias, Mohd Raziff; Mazlan, Luqman; Sagap, Ismail; Jamal, Rahman

doi:10.1016/j.canep.2019.101656

Cited by 5 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…FOBT is a simple screening method for CRC, which is suitable for rural areas, low‐income groups and people with poor compliance for colonoscopy. In China, the positive rate of FOBT among screened people was 14%, but in other Asian countries, the positive FOBT rate was 13.1% 13 …”

Section: Discussionmentioning

confidence: 93%

“…In China, the positive rate of FOBT among screened people was 14%, but in other Asian countries, the positive FOBT rate was 13.1%. 13 …”

Section: Discussionmentioning

confidence: 99%

“…In China, the positive rate of FOBT among screened people was 14%, but in other Asian countries, the positive FOBT rate was 13.1%. 13 Because of lack of specificity and low sensitivity in the diagnosis for CRC, FOBT can only be used for the initial screening and follow-up population. Colonoscopy is the most intuitive and effective way for CRC screening in Chinese high-risk areas, which is conducive to early detection of CRC and precancerous lesions.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Using period analysis to timely assess and predict 5‐year relative survival for colorectal cancer patients in Taizhou, eastern China

et al. 2022

View full text Add to dashboard Cite

Introduction While timely assessment of long‐term survival for patients with colorectal cancer (CRC) is essential for evaluation on early detection and screening programs of colorectal cancer, those data are extremely scarce in China. We aimed to timely and accurately assess long‐term survival for CRC patients in eastern China. Methods Patients diagnosed with CRC during 2004–2018 and followed up until December 31, 2018 from four cancer registries with high‐quality data from Taizhou, eastern China were included. Period analysis was used to calculate 5‐year relative survival (RS) for overall and the stratification by sex, age at diagnosis and region. The projected 5‐year RS of CRC patients during 2019–2023 was also assessed using a model‐based period analysis. Results Overall 5‐year RS for patients with CRC during 2014–2018 reached 78.8%, being 74.9% for men and 86.1% for women. 5‐year RS declined along with aging, decreasing from 84.1% for age < 45 years to 48.9% for age > 74 years, while 5‐year RS for urban area was higher compared to rural area (83.9% vs. 75.8%). Projected overall 5‐year RS of CRC patients could reach 85.9% during the upcoming period 2019–2023. Conclusions We provided, for first time in China using period analysis, most up‐to‐date 5‐year RS for patients with CRC from Taizhou, eastern China and also found 5‐year RS for CRC patients have improved greatly during 2004–2018.

show abstract

Section: Discussionmentioning

confidence: 93%

“…In China, the positive rate of FOBT among screened people was 14%, but in other Asian countries, the positive FOBT rate was 13.1%. 13 …”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Using period analysis to timely assess and predict 5‐year relative survival for colorectal cancer patients in Taizhou, eastern China

et al. 2022

View full text Add to dashboard Cite

show abstract

“…On the bright side, studies (with large sample sizes of over 2000 people) revealed high CRC screening uptake (iFOBT) rates ranging from 79.6% to 94.7%. [11][12][13] Following that, these subjects had 60% good compliance rate with confirmatory colonoscopy. The willingness of patients to participate in CRC screening will definitely enhance uptake.…”

mentioning

confidence: 89%

Colorectal cancer screening in Malaysia: a critical situation that must be addressed

Teoh,

Christelle,

Thew

et al. 2024

Bangladesh J Med Sci

View full text Add to dashboard Cite

In Malaysia, colorectal cancer is the second most common cause of cancer. Early detection through screening programmes is one of the most important public health initiatives in reducing cancer-related death. For decades, Malaysia has a colorectal cancer screening program in government-funded primary care facilities. However, screening uptake is minimal and numerous theories have been postulated. The aim of this article is to explore the possible reasons for low colorectal screening uptake among primary care physicians. Bangladesh Journal of Medical Science Vol. 23 No. 01 January’24 Page : 278-280

show abstract

“…Meanwhile, more than two-thirds of the CRC patients in countries with a medium to high HDI presented to health facilities for care only at advanced stages of the disease [ 4 – 6 ]. Generally, the public awareness of CRC and the need for early screening remains poor worldwide, very often resulting in delayed diagnosis of the disease [ 7 – 10 ].…”

Section: Introductionmentioning

confidence: 99%

Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities

et al. 2021

View full text Add to dashboard Cite

The uptake of the immunochemical faecal occult blood test (iFOBT) in many countries with an opportunistic colorectal cancer (CRC) screening programme remains suboptimal. This study aimed to determine the rate, associated factors and reasons of refusal to perform the iFOBT test offered under an opportunistic CRC screening programme in semi-urban communities. This cross-sectional study was conducted among the average-risk individuals living in semi-urban areas, who sought care from public primary care centres across Kedah state, Malaysia. The information regarding the sociodemographic and clinical characteristics of individuals who were offered the iFOBT between January and April 2019, along with their willingness to perform the test, was gathered. The factors associated with the refusal were further explored using the logistic regression analysis. The individuals offered the iFOBT (n = 920) were mainly female (52.4%) and had a mean age of 58.7±10.6 years. The refusal rate of the iFOBT was 32.2%. Patients who did not have hypertension (adjusted OR: 3.33; 95% CI: 2.44, 4.54), did not have CRC symptoms (adjusted OR: 3.15; 95% CI:1.26, 7.89), had the test offered by either medical assistants (adjusted OR: 2.44; 95% CI: 1.71, 3.49) or nurses (adjusted OR: 2.41; 95% CI 1.65, 3.51), did not have diabetes (adjusted OR: 1.99; 95% CI: 1.42, 2.77),and were not active smokers (adjusted OR: 1.74; 95% CI: 1.22, 2.47), were more likely to refuse the iFOBT. The common reasons of refusing the test included “feeling not ready for the test” (21.6%) and “feeling healthy” (14.9%). The iFOBT was refused by one-third of the average-risk individuals from semi-urban communities. The associated factors and reasons of refusal found in this study could guide policymakers in developing targeted interventions to boost the uptake of CRC screening in Malaysia.

show abstract

Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants

Cited by 5 publications

References 26 publications

Using period analysis to timely assess and predict 5‐year relative survival for colorectal cancer patients in Taizhou, eastern China

Using period analysis to timely assess and predict 5‐year relative survival for colorectal cancer patients in Taizhou, eastern China

Colorectal cancer screening in Malaysia: a critical situation that must be addressed

Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities

Contact Info

Product

Resources

About